These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37611908)

  • 1. Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta-analysis.
    Bloch Priel S; Yitzhaky A; Gurwitz D; Hertzberg L
    Eur J Neurosci; 2023 Sep; 58(6):3540-3554. PubMed ID: 37611908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.
    Tao R; Li C; Jaffe AE; Shin JH; Deep-Soboslay A; Yamin R; Weinberger DR; Hyde TM; Kleinman JE
    Transl Psychiatry; 2020 May; 10(1):158. PubMed ID: 32433545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders].
    Martínez-Gras I; Hoecnika J; Pérez-Hernández E; Rodríguez-Jiménez R; Ponce G; Jiménez-Arriero M; Ramos-Atance J; Palomo T; Rubio G
    Actas Esp Psiquiatr; 2007; 35(2):122-9. PubMed ID: 17401783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cannabis and endocannabinoids in the genesis of schizophrenia.
    Fernandez-Espejo E; Viveros MP; Núñez L; Ellenbroek BA; Rodriguez de Fonseca F
    Psychopharmacology (Berl); 2009 Nov; 206(4):531-49. PubMed ID: 19629449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
    Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesity.
    Thethi TK; Sigel A; Japa S; Katalenich B; Liu S; Nguyen T; Larrazolo J; Syu S; Carefoot E; McDuffie R; Fonseca V
    J Diabetes Complications; 2020 Nov; 34(11):107682. PubMed ID: 32732136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia.
    Ujike H; Morita Y
    J Pharmacol Sci; 2004 Dec; 96(4):376-81. PubMed ID: 15613777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor type 2 gene is associated with comorbidity of schizophrenia and cannabis dependence and fatty acid amide hydrolase gene is associated with cannabis dependence in the Spanish population.
    Arias Horcajadas F; Dávila Píriz JR; Parra González A; Sánchez Romero S; Sánchez-Morla E; Ampuero Sánchez I; Ramos Atance JA
    Adicciones; 2023 Jan; 35(1):33-46. PubMed ID: 34171108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
    Monteleone P; Bifulco M; Di Filippo C; Gazzerro P; Canestrelli B; Monteleone F; Proto MC; Di Genio M; Grimaldi C; Maj M
    Genes Brain Behav; 2009 Oct; 8(7):728-32. PubMed ID: 19659925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans.
    Smith DR; Stanley CM; Foss T; Boles RG; McKernan K
    PLoS One; 2017; 12(11):e0187926. PubMed ID: 29145497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.
    Gouvêa ES; Santos AF; Ota VK; Mrad V; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
    Braz J Psychiatry; 2017; 39(2):160-171. PubMed ID: 28099629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    D'Addario C; Micale V; Di Bartolomeo M; Stark T; Pucci M; Sulcova A; Palazzo M; Babinska Z; Cremaschi L; Drago F; Carlo Altamura A; Maccarrone M; Dell'Osso B
    Schizophr Res; 2017 Oct; 188():132-140. PubMed ID: 28108228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.
    Bae JS; Kim JY; Park BL; Kim JH; Kim B; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
    Psychiatr Genet; 2014 Oct; 24(5):225-9. PubMed ID: 25014618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets.
    Aghamahdi F; Shafiee A; Rostami S; Mokhames Z; Safavi M; Yaslianifard S; Siami Z; Kabir K; Azizi G; Bakhtiyari M; Mozhgani SH
    Diabetes Metab Syndr; 2022 May; 16(5):102499. PubMed ID: 35580523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cannabinoid receptor genes (
    Peiró AM; García-Gutiérrez MS; Planelles B; Femenía T; Mingote C; Jiménez-Treviño L; Martínez-Barrondo S; García-Portilla MP; Saiz PA; Bobes J; Manzanares J
    Anxiety Stress Coping; 2020 May; 33(3):256-265. PubMed ID: 32114795
    [No Abstract]   [Full Text] [Related]  

  • 16. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
    Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
    Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients.
    Santoro M; Mirabella M; De Fino C; Bianco A; Lucchini M; Losavio F; Sabino A; Nociti V
    J Neurol Sci; 2017 Aug; 379():298-303. PubMed ID: 28716266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
    Ho BC; Wassink TH; Ziebell S; Andreasen NC
    Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.
    Bidwell LC; Metrik J; McGeary J; Palmer RH; Francazio S; Knopik VS
    J Stud Alcohol Drugs; 2013 Nov; 74(6):867-78. PubMed ID: 24172113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
    Di Bartolomeo M; Stark T; Maurel OM; Iannotti FA; Kuchar M; Ruda-Kucerova J; Piscitelli F; Laudani S; Pekarik V; Salomone S; Arosio B; Mechoulam R; Maccarrone M; Drago F; Wotjak CT; Di Marzo V; Vismara M; Dell'Osso B; D'Addario C; Micale V
    Pharmacol Res; 2021 Feb; 164():105357. PubMed ID: 33285233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.